Over the past decades, the intestinal microbiota has increasingly gained attention in studies addressing pathophysiology of (paediatric) autoimmune diseases, like inflammatory joint diseases, inflammatory bowel disease (IBD) and type 1 diabetes. In this study, we have analysed composition of gut microbiota of newly diagnosed juvenile idiopathic arthritis (JIA) patients, prior to initiation of disease-modifying antirheumatic drugs (DMARD). Faecal microbiota profiles of 8 JIA patients (median age 11,1 years, 6 girls) were compared to 22 healthy age-matched controls using IS-pro, a 16S-23S interspacer (IS) region-based, eubacterial molecular detection technique. By partial least squares discriminant analysis (PLS-DA), microbiota profiles of JIA and controls could significantly be discriminated based on a limited set of species belonging to the phylum Bacteroidetes (Figure 6 .2), with sensitivity of 88% and specificity of 73% Chapter6_tim.indd 110
INTRODUCTION
In the pathogenesis of Juvenile Idiopathic Arthritis (JIA) environmental triggers are con sidered to provoke the onset of symptoms in genetically susceptible hosts. 1 Autoreactive T-cell responses to yet unrecognized antigens have been described to trigger an inflammatory response. In adults the role of the intestinal microbiota in the aetiology of rheumatoid arthritis and other auto-immune diseases has been increasingly recognized. 2 Exemplary are Reactive arthritis after a gastro-intestinal infection and the association between arthritis and jejuno-ileal-bypass surgery. 3, 4 In the latter, disruption of gastrointestinal anatomy provokes microbial disturbance by small intestinal bacterial overgrowth, leading to antibody production and synovial inflammation. Multiple animal studies have established a link between the intestinal microbiota in the onset or reduction of arthritis. Illustrative is the occurrence of adjuvant-induced arthritis exclusively in rats grown in germ-free conditions. The potential immunomodulatory effect of the microbiome is also reflected in the protective role of some enterobacteria in arthritis-susceptible rats. 2 In humans with newonset rheumatoid arthritis (RA) one recently described example is the higher abundance of
Prevotella copri in combination with less Bacteroides compared to controls.
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In RA, disturbance of bacterial homeostasis (dysbiosis) is considered to provoke an increased mucosal permeability, loss of immune tolerance to microbial components and trafficking of immune cells and antigenic material to joints, provoking an inflammatory cascade leading to RA. 5 Analogue to RA, an aetiological role for the gut microbiota has been suggested in JIA. [6] [7] [8] [9] Comparable observations on alterations in microbiota are currently rapidly accumulating for other paediatric auto immune diseases, like type 1 diabetes 10 and IBD. 11 However, despite recognition of disease-specific microbial signatures for different diseases, it remains largely unclear whether microbial changes precede or are rather a consequence of these diseases.
Aim of this prospective, case-control study was to describe composition and diversity of intestinal gut microbiota of children with new-onset, DMARD-naive JIA, compared to agematched, healthy controls. 
MATERIALS AND METHODS

Ethical considerations
This study was conducted according to the principles expressed in the Declaration of Helsinki. The protocol was approved by the Medical Ethical Committee from the Leiden University Medical Center. JIA patients and parents signed a written informed consent.
IS-pro
We used IS-pro, an eubacterial molecular detection technique to characterize the microbiota. 13, 14 IS-pro makes use of phylum-specific fluorescently labelled PCR primers and differentiates bacterial species by the length of the 16S-23S rDNA IS region. For a detailed description of the used protocol on DNA isolation and sample preparation we refer to previous report. 13, 14 The procedure consists of two separate multiplex PCRs: the first PCR separating fragments on an agarose gel and excising and sequencing these fragments.
Sequences were compared to the GenBank database with the BLAST algorithm. Taxonomic classification to species level was based on > 97% sequence identity.
14 Within-sample microbial diversity was calculated as the Shannon diversity index based on the resulting profiles using the R 2.15.2 software package. Diversity was calculated both per phylum and for overall microbial composition (by pooling the phyla FAFV, Bacteroidetes and Proteobacteria together). A p-value of < 0.05 was considered statistically significant.
Partial least squares discriminant analysis (PLS-DA) regression, a supervised classification technique, was used for the prediction of the clinical status of faecal samples, JIA or healthy. 15 This statistical model was performed for each phylum and for all phyla together to predict case-control classification. Validation of this PLS-DA model was carried out by a 10-fold cross-validation procedure. 16 In practice, the dataset was split into 90% of samples for model construction (i.e., training set), with the aim to predict the other 10% (i.e., test set).
This procedure was repeated for ten iterations, where each sample served as a test sample exactly once. Accuracy rates, specificity, and sensitivity were computed for the samples that were used as a test set in every iteration, and the model predictive power was further assessed using a receiver operating characteristic (ROC) curve with calculation of the Area
Under the Curve (AUC) and 95% CI values.
RESULTS
All included patients suffered from polyarticular rheumatoid factor negative JIA. Other patient characteristics are shown in 
DISCUSSION
In this study we have shown that gut microbiota in JIA can be discriminated from matched controls with high accuracy, based on a limited set of species belonging to of the phylum
Bacteroidetes. In a recent study by Tejesvi et al., 6 faecal microbiota analysis of 30 patients with newly onset JIA revealed an increased abundance of species belonging to the phylum Bacteroidetes, in particular Bacteroides spp., and a low abundance of bacteria within the phylum of Firmicutes compared to controls6. Secondly, Stoll et al. 7 observed a reduced abundance of faecal F. prausnitzii in juvenile enthesitis related arthritis (ERA) patients compared to controls. Additionally, a non-statistically significant increased abundance in Bacteroides spp. and Akkermansia municiphila was observed in subsets of ERA patients, suggesting a role for a humoral response to these specific species in the pathophysiology. 7 An increased abundance of Bacteroides spp. was observed in paediatric ERA patients, with decreased abundance of Prevotella spp. 8 Di Paola et al. described different microbial profiles between JIA-ERA patients and non-ERA patients versus healthy controls and, notably, also between active disease and remission state. 9 Similar alterations in microbiome were previously reported in paediatric type 1 diabetes and IBD. 10, 11 This study adds as novelty the increased knowledge on the composition of the microbiota of a large control group of healthy children. 13 In that study, species within the phylum Bacteroidetes were described to be dominant members of a shared microbial core in healthy state. 13 Notably, we found in the present study that JIA could be differentiated from controls based on alterations in the abundance of species belonging to this healthy core. This suggests that onset of JIA may be associated with disruption of this microbial core and that JIA-related dysbiosis is rather reflected by a loss of healthy microbial state than by the introduction of pathogens. The high accuracy to discriminate new onset JIA from healthy state based on a limited number of bacterial species, as observed in this study, may have several implications. Firstly, a microbiota-based test with high sensitivity may have the potential to serve as a diagnostic tool in clinical practice. However, to reliable assess the potential of microbiota analysis as a diagnostic instrument, comparison with an intention-todiagnose cohort, including children with suspected JIA, is preferable, and has to be tested in future studies. Secondly, the presence of a JIA-specific microbial signature, which can robustly discriminate diseased state from controls could possibly allow for the development of microbiota targeted therapeutic or even preventive interventions in JIA treatment.
Future studies are needed to externally validate our findings, to address the significance of the observed disturbance of core species and to assess whether clinical remission of JIA merges with restoration of this core. In a recent review, an overview was given of current knowledge on the role of gut microbiota in JIA aetiology, including factors possibly predisposing to dysbiosis, and mechanisms by which altered microbiota might predispose to arthritis. 17 Important factors influencing the composition of microbiota are mode of delivery, 18 feeding habits in early life 19 and exposure to (multiple) medication, in particular antibiotics. 17 Sex related differences and body morphometrics have also been described to affect microbiota composition, however, in the control group of this study, microbial communities did not differ between both sexes. [20] [21] [22] [23] Limitation of this study is that the cohort was too small to take different environmental factors possibly affecting microbiota composition into account, increasing the risk for type I error.
In conclusion, our observation of intestinal dysbiosis in new onset JIA confirms the increasing notion that aberrant microbiota composition may play a role in the aetiology of JIA. In particular, we found compositional alterations in species within the phylum Bacteriodetes, which have been described dominant members of a microbial core in healthy state.
Expanding knowledge on JIA-specific microbial signatures and host-interactions may open opportunities to explore the options to develop individualized, microbiota-based preventive and therapeutic interventions in JIA.
